⚕️
Medikal Tanı ve Test Sektörü Hisseleri
Medikal Tanı ve Test Sektörü altında 222 Hisse Senedi
Medikal Tanı ve Test sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
100
Toplam Hisse
$19.6B
Toplam Piyasa Değeri
Medikal Tanı ve Test Sektörü Hisseleri
Sayfa 2/3 (Toplam: 222)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM |
|---|---|---|---|---|
| RGLS | Regulus Therapeutics Inc. | $564.95M | $8.16 | 0.00% |
| CTMX | CytomX Therapeutics, Inc. | $554.11M | $3.36 | 2.61% |
| ABSI | Absci Corporation | $550.24M | $3.68 | 8.23% |
| NUTX | Nutex Health, Inc. | $526.79M | $94.83 | 8.54% |
| ARCT | Arcturus Therapeutics Holdings Inc. | $514.58M | $18.95 | 3.71% |
| AVNS | Avanos Medical, Inc. | $496.51M | $10.70 | 4.89% |
| CTKB | Cytek Biosciences, Inc. | $489.81M | $3.85 | 2.28% |
| LAB | Standard BioTools Inc. | $488.95M | $1.28 | 5.88% |
| EBS | Emergent BioSolutions Inc. | $483.89M | $9.07 | 9.66% |
| INBX | Inhibrx Biosciences, Inc. | $470.26M | $32.47 | 7.24% |
| CBLL | CeriBell, Inc. | $438.13M | $11.95 | 6.79% |
| CGEM | Cullinan Oncology, Inc. | $437.15M | $7.40 | 4.96% |
| BVS | Bioventus Inc. | $435.47M | $6.51 | 1.21% |
| PRTC | PureTech Health plc | $428.09M | $17.60 | 4.09% |
| PACB | Pacific Biosciences of California, Inc. | $426.53M | $1.42 | 7.19% |
| SMLR | Semler Scientific, Inc. | $396.62M | $26.80 | 5.37% |
| EHAB | Enhabit, Inc. | $392.85M | $7.75 | 3.13% |
| LCTX | Lineage Cell Therapeutics, Inc. | $379.07M | $1.66 | 5.14% |
| MLAB | Mesa Laboratories, Inc. | $372.61M | $67.73 | 5.48% |
| AURA | Aura Biosciences, Inc. | $367.75M | $5.92 | 1.82% |
| CATX | Perspective Therapeutics, Inc. | $361.25M | $4.87 | 26.04% |
| TOI | The Oncology Institute, Inc. | $354.34M | $3.79 | 3.07% |
| SENS | Senseonics Holdings, Inc. | $342.17M | $0.42 | 6.25% |
| ANNX | Annexon, Inc. | $340.64M | $3.10 | 4.91% |
| QSI | Quantum-Si incorporated | $338.12M | $1.67 | 4.02% |
| CAPR | Capricor Therapeutics, Inc. | $324.13M | $7.09 | 6.96% |
| CERS | Cerus Corporation | $306.72M | $1.60 | 4.19% |
| ALEC | Alector, Inc. | $305.66M | $3.02 | 3.82% |
| GALT | Galectin Therapeutics Inc. | $302.32M | $4.72 | 0.63% |
| TECX | Tectonic Therapeutic, Inc. | $299.77M | $16.02 | 6.21% |
| MG | Mistras Group, Inc. | $296.14M | $9.39 | 1.78% |
| MASS | 908 Devices Inc. | $288.69M | $8.00 | 9.09% |
| QTRX | Quanterix Corporation | $262.07M | $5.64 | 5.84% |
| NEO | NeoGenomics, Inc. | $231.81M | $9.10 | 1.51% |
| PYXS | Pyxis Oncology, Inc. | $229.47M | $3.70 | 3.39% |
| IMRX | Immuneering Corporation | $222.53M | $6.13 | 1.76% |
| OM | Outset Medical, Inc. | $221.19M | $12.45 | 17.60% |
| OSUR | OraSure Technologies, Inc. | $215.75M | $2.95 | 5.45% |
| ARAY | Accuray Incorporated | $199.39M | $1.77 | 4.32% |
| OABI | OmniAb, Inc. | $198.25M | $1.61 | 11.26% |
| BIOA | BioAge Labs, Inc. | $191.80M | $5.35 | 1.83% |
| GNLX | Genelux Corporation | $191.51M | $5.07 | 10.58% |
| SAVA | Cassava Sciences, Inc. | $180.67M | $3.74 | 10.74% |
| MCRB | Seres Therapeutics, Inc. | $167.39M | $19.12 | 1.95% |
| ANRO | Alto Neuroscience, Inc. | $152.70M | $5.64 | 6.31% |
| ANIX | Anixa Biosciences, Inc. | $142.52M | $4.33 | 11.99% |
| RPID | Rapid Micro Biosystems, Inc. | $141.32M | $3.21 | 10.59% |
| ATOS | Atossa Therapeutics, Inc. | $139.51M | $1.08 | 8.47% |
| HYPR | Hyperfine, Inc. | $137.72M | $1.75 | 11.62% |
| INO | Inovio Pharmaceuticals, Inc. | $136.58M | $2.57 | 3.02% |
| ABOS | Acumen Pharmaceuticals, Inc. | $129.63M | $2.14 | 4.89% |
| AGEN | Agenus Inc. | $126.50M | $3.97 | 6.59% |
| TCRX | TScan Therapeutics, Inc. | $125.07M | $2.21 | 1.84% |
| SEER | Seer, Inc. | $124.52M | $2.21 | 4.33% |
| OVID | Ovid Therapeutics Inc. | $118.75M | $1.67 | 4.02% |
| LUCD | Lucid Diagnostics Inc. | $117.18M | $1.15 | 6.50% |
| SERA | Sera Prognostics, Inc. | $113.51M | $3.06 | 4.38% |
| DCGO | DocGo Inc. | $112.48M | $1.15 | 4.17% |
| NAUT | Nautilus Biotechnology, Inc. | $107.44M | $0.85 | 5.49% |
| MGNX | MacroGenics, Inc. | $106.82M | $1.69 | 3.43% |
| ICAD | iCAD, Inc. | $106.31M | $3.87 | 3.75% |
| COYA | Coya Therapeutics, Inc. | $101.52M | $6.07 | 3.19% |
| OCX | OncoCyte Corporation | $91.52M | $3.20 | 17.22% |
| STTK | Shattuck Labs, Inc. | $88.14M | $1.84 | 16.36% |
| ALXO | ALX Oncology Holdings Inc. | $87.82M | $1.64 | 15.46% |
| IPA | ImmunoPrecise Antibodies Ltd. | $83.54M | $1.81 | 8.12% |
| IGMS | IGM Biosciences, Inc. | $77.50M | $1.27 | 0.00% |
| AEMD | Aethlon Medical, Inc. | $76.29M | $0.69 | 5.90% |
| IMMX | Immix Biopharma, Inc. | $72.02M | $2.50 | 3.10% |
| STRO | Sutro Biopharma, Inc. | $68.13M | $0.80 | 6.00% |
| CVM | CEL-SCI Corporation | $66.14M | $9.61 | 3.22% |
| AKYA | Akoya Biosciences, Inc. | $64.44M | $1.29 | 5.15% |
| LUNG | Pulmonx Corporation | $64.38M | $1.58 | 8.67% |
| CUE | Cue Biopharma, Inc. | $61.13M | $0.80 | 14.12% |
| BEAT | HeartBeam, Inc. | $56.61M | $1.65 | 6.78% |
| BDSX | Biodesix, Inc. | $53.67M | $7.32 | 6.51% |
| BCAB | BioAtla, Inc. | $50.94M | $0.87 | 14.95% |
| MAIA | MAIA Biotechnology, Inc. | $50.15M | $1.52 | 11.63% |
| INMB | INmune Bio, Inc. | $49.45M | $1.86 | 6.06% |
| NOTV | Inotiv, Inc. | $47.75M | $1.39 | 4.14% |
| CELU | Celularity Inc. | $47.07M | $2.05 | 3.76% |
| LTRN | Lantern Pharma Inc. | $46.87M | $4.34 | 6.06% |
| SNTI | Senti Biosciences, Inc. | $44.21M | $1.69 | 11.05% |
| PDSB | PDS Biotechnology Corporation | $44.21M | $0.95 | 3.92% |
| JSPR | Jasper Therapeutics, Inc. | $39.01M | $2.40 | 3.61% |
| CCEL | Cryo-Cell International, Inc. | $35.65M | $4.43 | 0.12% |
| RENB | Renovaro Biosciences Inc. | $32.92M | $1.42 | 0.00% |
| RNTX | Rein Therapeutics Inc. | $30.24M | $1.30 | 5.11% |
| PRPO | Precipio, Inc. | $28.51M | $19.04 | 3.16% |
| BOLD | Boundless Bio, Inc. | $28.43M | $1.27 | 0.78% |
| NNVC | NanoViricides, Inc. | $23.88M | $1.37 | 3.86% |
| PRPH | ProPhase Labs, Inc. | $21.85M | $0.53 | 2.83% |
| ELEV | Elevation Oncology, Inc. | $21.63M | $0.36 | 2.12% |
| FEMY | Femasys Inc. | $19.91M | $0.61 | 5.64% |
| SYBX | Synlogic, Inc. | $19.65M | $1.68 | 1.75% |
| FBLG | FibroBiologics, Inc. Common Stock | $18.92M | $0.45 | 7.32% |
| LGVN | Longeveron Inc. | $17.11M | $0.81 | 8.17% |
| AYTU | Aytu BioPharma, Inc. | $14.82M | $2.36 | 5.98% |
| CTXR | Citius Pharmaceuticals, Inc. | $13.74M | $1.23 | 3.91% |
| IBIO | iBio, Inc. | $13.08M | $0.79 | 7.34% |